Literature DB >> 34787925

Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.

Jeroen Luyten1, Sandy Tubeuf2, Roselinde Kessels3,4.   

Abstract

In the face of limited COVID-19 vaccine supply, governments have had to identify priority groups for vaccination. In October 2020, when it was still uncertain whether COVID-19 vaccines would be shown to work in trials, we conducted a discrete choice experiment and a best-worst ranking exercise on a representative sample of 2060 Belgians in order to elicit their views on how to set fair vaccination priorities. When asked directly, our respondents prioritized the groups that would later receive priority: essential workers, the elderly or those with pre-existing conditions. When priorities were elicited indirectly, through observing choices between individuals competing for a vaccine, different preferences emerged. The elderly were given lower priority and respondents divided within two clusters. While both clusters wanted to vaccinate the essential workers in the second place, one cluster (N = 1058) primarily wanted to target virus spreaders in order to control transmission whereas the other cluster (N = 886) wanted to prioritize those who were most at risk because of a pre-existing health condition. Other strategies to allocate a scarce resource such as using a "lottery", "first-come, first-served" approach or highest willingness-to-pay received little support.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; discrete choice experiment; distribution; efficiency; equity; justice; priority; public preferences; scarcity; vaccine

Mesh:

Substances:

Year:  2021        PMID: 34787925      PMCID: PMC9116477          DOI: 10.1002/hec.4450

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   2.395


INTRODUCTION

From November 2020 onwards, several vaccines that protect against the SARS‐CoV‐2 virus have become available (Bloom et al., 2020; Mahase, 2020; Mallapaty & Ledford, 2020). However, the initial supply was insufficient to vaccinate all (Wouters, Shadlen, Salcher‐Konrad, et al., 2021) and throughout most of 2021 strict rationing has been required worldwide. First, there were problems of fairly distributing the vaccine internationally, across countries and continents (Emanuel, Persad, Kern, et al., 2020). Second, and this is the focus of this paper, at national levels, priority groups for vaccination needed to be designated (Emanuel, Persad, Upshur, et al., 2020; Persad et al., 2020; Schmidt, 2020; Subbaraman, 2020). Almost unanimously, policy makers and expert groups selected the same groups for priority access: the highest risk categories – the elderly, those with pre‐existing conditions, and essential workers, which include front‐line health care professionals (CDC, 2020; European Commission, 2020; Gayle et al., 2020; JCVI, 2020; World Health Organization, 2020). Nonetheless, there could have been “reasonable disagreement” about ethical prioritization of a COVID‐19 vaccine. As already illustrated earlier during the pandemic with scarcity of mechanical ventilation in intensive care units, how to ration a life‐saving resource is never obvious (Emanuel, Persad, Upshur, et al., 2020; Liu et al., 2020; Persad et al., 2020; Roope et al., 2020). In the context of vaccines, fair rationing is even less straightforward because vaccines usually serve two separate functions: to prevent death and illness within the vaccinated individuals but also to reduce transmission toward others. In this study, we investigated several allocative mechanisms to set vaccination priorities and their acceptability toward the general public. This is in the first place interesting from a scientific perspective. The circumstances of the pandemic present a unique research opportunity to investigate how people want to share a life‐saving resource across the population. Their views are not elicited from an artificial, abstract context of scarcity, but from a concrete reality in which they are all directly involved parties. At the time of the survey, the circumstances allowed us to consider a sufficient level of abstraction; it was still unclear whether vaccines would become available at all, and if available, which properties and effectiveness they would have. This made it easier to focus on broad distributive principles regarding how to ration a critical resource, abstracting from issues such as side effects related to specific vaccines. Second, understanding the public's opinion is important for policy reasons as public involvement has already been highly instrumental in the COVID‐19 pandemic for measures such as physical distancing, face masks or lockdowns to be effective (Chernozhukov et al., 2021; Mitze et al., 2020). In general, greater public and patient involvement in health care decisions, especially those with large stakes and a substantial ethical component, is increasingly considered important (Florin & Dixon, 2004). Our first study objective was to ask a representative sample of the general population in Belgium to rank eight alternatives to distributing the first COVID‐19 vaccines in their preferred order. Our second objective was to study further the respondents' preferences by letting them choose whom they would vaccinate over multiple pairs of concrete individuals competing for a vaccine. We finally summarize the overall preferences in a choice model that allowed us to calculate a vaccine priority score for specific population subgroups. What we found is that, when asked directly, people confirmed the three subgroups that policy makers eventually selected of highest priority: those with pre‐existing conditions, essential workers and the elderly. However, when we elicited their priorities through observing actual priority setting choices between individuals, high virus spreaders were given higher priority, while elderly received lower priority. We also identified two clusters of respondents: one that wanted to target those individuals who spread the virus, and the other that wanted to target those who are worst‐off through pre‐existing conditions. The paper proceeds as follows. Section 2 provides a summary of the previous literature. Section 3 describes the design of the survey and the two experiments and presents the methods for data analysis. Section 4 displays the results. Finally, we provide some concluding remarks.

BACKGROUND

Empirical evidence on public preferences toward COVID‐19 vaccines was inexistent at the time of our survey and remains scarce. While Borriello et al. (2021) collected the preferences of Australians regarding hypothetical COVID‐19 vaccines, their study did not focus on vaccine allocation but described vaccines according to seven attributes (i.e., incidence of mild and major side effects, effectiveness, mode of administration, location of administration, time to availability and cost). Public preferences in COVID‐19 vaccine allocation strategies were examined in Gollust et al. (2020) where a sample of 1004 adults representative of the US population were asked to indicate among eight alternative groups based on age, health risk and employment type whom should receive high, medium, or low priority to vaccination. They found that respondents had a high willingness to allocate vaccines to front‐line medical workers, essential non‐medical workers, high‐risk children, and older adults. More recently, preferences of US adults' regarding vaccine prioritization were analyzed as part of two surveys (Persad et al., 2021); they both showed that people would prioritize health care workers and adults of any age with serious comorbidity among their top four priority groups. Healthy older adults were however not ranked within highest priority groups to vaccination, especially among older respondents. Most respondents were in agreement with the phased allocation strategy proposed by the National Academies of Science, Engineering, and Medicine (CDC, 2020) but placed a lower priority on vaccinating healthy older adults. Finally, an online conjoint experiment in 13 countries was carried out to identify preferences for different vaccine prioritization schemes based on five attributes (occupation, age, coronavirus transmission status, risk of death from COVID‐19 and income) and between three and eight levels (Duch et al., 2021). This large‐scale study showed that most countries favored access to vaccines to individuals at higher risk of COVID‐19 death and higher risk of COVID‐19 transmission, to essential workers and non‐essential workers unable to work from home, to older individuals and to individuals in low‐income categories. Our study adds to this literature. It provides a unique ranking exercise of allocation strategies including priority groups along with standard strategies used in the context of scarce resources allocation. It also provides a discrete choice experiment (DCE) for COVID‐19 vaccine allocation at national level comparing hypothetical individuals described on five key attributes.

METHODS

Sample and survey

We used a nationally representative panel of the market research agency Dynata to complete a survey between October 6, 2020 and October 16, 2020. A sample of 2698 respondents drawn from a panel of 5500 selected members who mirror the Belgian population (aged 18–80 years) as well as possible, were invited to participate in the survey. Of these, 494 did not complete the survey and 144 were excluded because they did not meet the company's internal quality controls (e.g., they completed the survey unreasonably fast: below a third of the median time to completion). This left us with a sample of 2060 respondents, which fulfilled pre‐determined Belgium quota for age, gender, level of education and province. The survey first asked respondents for a range of sociodemographic characteristics along with their financial situation, general health status, attitudes toward vaccination and toward the government's handling of the corona crisis, whether they had had COVID‐19, whether someone they knew had had it, had been hospitalized or died because of it. Respondents were also asked whether their profession was among the “essential professions” (i.e., those that were obliged to keep working during the first “lockdown” in March/April 2020) and whether they considered themselves to be part of a risk group for COVID‐19 and if so, which group they belonged to (i.e., old age, chronic illness, obesity, or other). The questionnaire was then followed with an explanation of the background to the study where we explicitly asked the respondents to think about what they considered fairest to society when allocating the limited first supply of COVID‐19 vaccines, and not to choose simply what would be most advantageous to themselves. After the ranking exercise and the choice experiment, respondents were asked about whom should decide who gets the COVID‐19 vaccine first (government, scientists or the population), whether they would choose to be vaccinated themselves once a vaccine becomes available, and how easy they found answering the survey.

Ranking exercise

We presented the respondents with eight alternative strategies to distribute the COVID‐19 vaccines summarized in Table 1. Each strategy was presented one after the other using successive new screens that respondents were only able to progress from every 10 s. The eight strategies were then summarized as a list in their short version (with the possibility to go back to the full explanation if needed) and respondents were asked to rank all of them from “most suitable” to “least suitable” according to their opinion. They were told that the vaccine was equally safe and effective in all people and that they should think about what would be the best allocation not for their self‐interest but for the society as a whole.
TABLE 1

Eight strategies to distribute a COVID‐19 vaccine

Strategy (in short)Full explanation as presented in the experiment
Prioritizing chronically illWe could first give the vaccine to people who are medically most at risk of serious illness and death because they have another underlying condition: Cancer patients, people with lung disease, heart disease, kidney disease, severe obesity, etc. By vaccinating them first, we would protect the people most vulnerable to the virus.
Prioritizing the elderlyWe could first give the vaccine to people over 60 years old. We know that, on average, these people run a much higher risk of serious illness or death from a corona infection. By vaccinating them first, we would protect the people most vulnerable to the virus.
Prioritizing spreadersWe could first give the vaccine to the people who spread the virus the most because they have a lot of social contacts in their daily life (at work, at school, in their neighborhood, in public transport, etc.). These people themselves are not at high risk of serious illness or death from COVID‐19, but they can infect many others. By vaccinating them first, we would slow down the spread of the virus as much as possible.
Prioritizing workersPeople who work will cause a greater economic cost when they become ill than those who do not work. By first vaccinating working people, we would ensure that the virus does as little further damage as possible to the economy.
Prioritizing essential professionsSome professions are more “essential” to society than others. During the pandemic, health workers, hospital staff, police and garbage services had to continue working as usual, while others had to work from home or were temporarily unemployed. By prioritizing workers from these vital sectors, we would protect the normal functioning of society.
LotteryWe could distribute the available vaccines randomly among the population, for example through a lottery. Therefore, each individual would have the same chance to be vaccinated, regardless of their health risk or the social impact of an infection.
First‐come, first‐servedWe could distribute the available vaccines to the population according to the principle “first‐come, first‐served.” People who present themselves the fastest for vaccination at the doctor, pharmacy or government would be given priority from the moment there is a vaccine.
MarketWe could sell the available vaccines to the highest bidder. The people who want to pay the most money for a vaccine would be given priority.
Eight strategies to distribute a COVID‐19 vaccine

Discrete choice experiment

We then subjected respondents to a DCE. This is a widely used survey method to study individuals' preferences, especially in health care settings (Louviere et al., 2000; Ryan et al., 2008) including patients prioritization (Bryan & Dolan, 2004; Diederich et al., 2012; Luyten et al., 2015, 2019; Ratcliffe et al., 2009). Participants are presented with a series of choice sets, consisting of two or more products or services that are described by the same attributes with differing attribute levels. By observing a large number of choices, researchers can infer how attributes and levels implicitly determine the value of the good under evaluation. Here, we asked respondents to choose whom they would vaccinate from two hypothetical people candidates to the COVID‐19 vaccine. Both candidates were described with identical attributes, but they differed in the levels of these attributes so that we could infer how important these attributes were to the respondents when prioritizing one or the other candidate for vaccination.

Attributes and levels

The DCE focused on the five attributes of people that are considered most relevant by experts (Liu et al., 2020; Persad et al., 2020; Roope et al., 2020) as well as policy institutions (European Commission, 2020; Gayle et al., 2020; World Health Organization, 2020) to claim to priority: (1) their age, (2) whether they belonged to a medically vulnerable group due to pre‐existing conditions (e.g., diabetes, cancer, HIV, cardiovascular disease, obesity, etc.), (3) their cost to the economy if COVID‐19 infected, (4) whether their profession is considered “essential” (e.g., health care workers, policemen, firemen, etc.), and (5) whether they would spread the virus to many or few other people in case of infection (see Table 2). The remaining strategies used in the ranking exercise (lottery, market, first‐come first‐served) were excluded from the DCE.
TABLE 2

Attributes and levels used in the DCE

AttributeLevels
Medical risk group⁃ Someone who has no underlying conditions
⁃ Someone who has higher risk through chronic illness
Age⁃ Someone who is younger than 60 years
⁃ Someone who is at least 60
Virus spreader⁃ In case of infection, someone who is expected to contaminate 1 other person
⁃ In case of infection, someone who is expected to contaminate 10 other persons
Cost to society⁃ In case of infection, someone who is expected to cost society 0 € per day
⁃ In case of infection, someone who is expected to cost society 100 € per day
⁃ In case of infection, someone who is expected to cost society 1000 € per day
Essential profession⁃ Someone who has a profession that is considered “essential”
⁃ Someone who has a profession that is considered not “essential”

Abbreviation: DCE, discrete choice experiment.

Attributes and levels used in the DCE Abbreviation: DCE, discrete choice experiment.

Design

We designed the DCE using “partial profiles”, that is, we kept the levels of two attributes constant between the two candidate profiles and only varied the levels of three attributes (Kessels, Jones, & Goos, 2011, 2015). We colored the varying levels of each profile to make them stand out in the choice sets (Jonker et al., 2019). An example of a choice set appears in Figure 1. Varying the levels of only three attributes and highlighting them made the choice tasks easier to perform and therefore respondents' choices more consistent and valid for the analysis. Respondents even testified that despite the choice problem had been quite difficult, it had been doable thanks to the design strategy. Because the varying attributes differed between choice sets, the partial profile design also helped prevent respondents from using lexicographic decision rules, by which profile alternatives are first compared on the most important attribute, then on the second most important attribute, and so forth, until one profile remains. If one or more dominant attributes are held constant, respondents can trade off the remaining attributes more easily, and not divert to non‐compensatory decision‐making. The statistical efficiency of a partial profile design is, however, reduced compared to a full profile design, in which all attributes can vary in the choice sets, but this is generally offset by more consistent choices (Louviere et al., 2008).
FIGURE 1

Example of a choice set

Example of a choice set The statistical design or the specific composition of the choice profiles we generated was “D‐optimal” within a Bayesian framework (Kessels, Jones, Goos, & Vandebroek, 2011). A D‐optimal design makes it possible to examine the importance of the attributes and their levels with maximum precision. The Bayesian addition means that prior information is taken into account in the design generating process so that choice sets with a dominant profile are largely avoided (Crabbe & Vandebroek, 2012). The complete design of the DCE consisted of 30 choice sets that we split into three different blocks of 10 choice sets and was efficiently constructed to estimate all two‐way interaction effects between the attributes (see Appendix B for the design and the design generating process). A representative sample of respondents were assigned in three similar groups to each of the three blocks. The 10 choice sets of each survey were presented in a random order to counteract a possible order effect of the choice sets. At the start of the DCE, we presented the respondents with a mock choice set that was identical to the last choice set in their survey and allowed us to analyze consistency in their choices. We first tested various visualizations among a convenience sample (N = 10) and then carried out a pilot study of the full survey in 174 respondents. After correcting for a few minor issues, we went ahead with the full launch of the study in 2060 respondents.

Statistical analysis

We analyzed the choice data by estimating a panel mixed logit (PML) model using the hierarchical Bayes technique in the JMP Pro 16 Choice platform (based on 10,000 iterations, with the last 5000 used for estimation; SAS Institute Inc.). This model assumes normally distributed utility parameters over the respondents to accommodate unobserved heterogeneity in the respondents' preferences. The mean utility function is thereby the sum of the mean attribute effects (Train, 2009). We first estimated a PML model for the entire sample and then investigated the heterogeneity in the individual utility estimates by comparing the subject standard deviations to the mean attribute effects. These subject standard deviations were of the same size or even larger than the mean estimates, indicating the need to identify respondent segments. We therefore clustered the individual utility estimates from the PML model using Ward's hierarchical cluster analysis and estimated separate PML models for each cluster. This second‐stage PML analysis for every cluster allows revealing differing and even opposing preferences between clusters (if there are). This procedure with a post‐estimation cluster analysis has already shown its merits in a DCE measuring public preferences for vaccination programs (Luyten et al., 2019) and a DCE predicting the uptake of the COVID‐19 digital contact‐tracing app (Mouter et al., 2021). To verify the cluster formation, we estimated latent class models with different numbers of classes using the lclogit2 package in Stata 17 (Yoo, 2020) as a more direct alternative to the two‐step PML procedure. A latent class model assumes a discrete distribution for the heterogeneous utility parameters instead of the normal distribution underlying the PML analysis. By relaxing the normality assumption, a latent class model allows capturing multimodal utility distributions directly in the event of diverging or opposing preferences between respondents. This model is therefore particularly suited in the context of segmented samples of respondents (Goossens et al., 2014). Louviere (2006) recommended to use latent class models more frequently because they would often fit the data at least as good as PML models and are easy to interpret. Once we distinguished clear and meaningful respondent segments, we characterized them through bivariate chi‐square analyses on the respondents' covariates and multiple logistic regression with the cluster membership as response variable and the respondents' covariates as explanatory variables. In all our analyses, we used a significance threshold of 5%.

RESULTS

On average, the 2060 respondents took 29 min to complete the survey. The median completion time was 15 min, with the interquartile range between 13 and 20 min. When asked how difficult completion of the survey was, only 21 respondents (1%) indicated it was “too difficult” whereas 1154 (56%) found it “easy” and 43% “difficult but doable.” A sample of 1577 respondents (77%) gave the same answer twice to the repeated choice set, however differing answers do not point at invalid answers as the strength of preferences can be weak in this context. We observed that 116 respondents (6%) gave the same answer throughout the DCE and are therefore called “straightliners.” As their number is considerable and their answers unlikely to match their choices, we followed standard practice in excluding these straightliners as a way of caution not to lower the quality of the data (Johnson et al., 2019; Sandorf, 2019). This left us with 1944 respondents for the analysis. Overall, the analysis sample included 39% of respondents considering themselves part of a specific COVID‐19 risk group. A minority (<20%) of the sample experienced a COVID‐19 infection themselves or in their immediate proximity. A majority (59%) reported being dissatisfied with the government's approach to the crisis. A large majority of respondents (78%) thought that the vaccine allocation decision should ultimately be determined by scientists; 10% thought the government should decide and 12% thought that it should be the population only. When asked whether they would become vaccinated with a COVID‐19 vaccine, 74% responded affirmatively (see Table 3).
TABLE 3

Sample characteristics

VariablesCategories N Percentage (%)
Respondents' general background
GenderFemale99351
Male95149
Age18–2419410
25–3433017
35–4433117
45–5437919
55–6432117
65–8038920
LanguageDutch111257
French83243
ProvinceVlaams‐Brabant19110
Brabant Wallon1297
Brussels Capital1769
Antwerpen28815
Limburg1578
East Flanders24913
West Flanders20010
Hainaut1156
Liège18610
Luxembourg1025
Namur1518
EducationNone70
Primary school613
First degree secondary school18710
Second degree secondary school24713
Third degree secondary school68435
Higher education (non‐university)46824
University or post‐university education26814
PhD141
Other80
Have childrenYes121362
No73138
ProfessionWorking97850
Homemaker804
Student1588
Unemployed1297
Disabled1277
Retired47224
Difficulties with monthly expensesNever80241
Once a year42222
Once every 3 months39120
Every month32917
Self‐assessed healthVery good24814
Good74141
Rather good60234
Bad1679
Very bad221
Don't know/don't want to say141
Respondents' COVID‐19 related background
Self‐reported membership of a COVID‐19 risk groupNo118361
Yes, elderly36619
Yes, chronically ill40021
Yes, severe obesity1246
Yes, other683
Self‐reported profession is labeled as “essential”Yes36719
No157781
Has had a COVID‐19 infectionYes, confirmed with a test573
Probably, but not confirmed with a test1608
No172789
Know personally someone who has had COVID‐19Yes, confirmed with a test29315
Probably, but not confirmed with a test1759
No147676
Know personally someone who was hospitalized for COVID‐19Yes1186
No182694
Know personally someone who died of COVID‐19Yes834
No186196
Satisfaction with government's approach to COVID‐19 pandemicVery satisfied583
Rather satisfied72938
Rather dissatisfied78740
Very dissatisfied37019
Determination of the vaccine prioritization strategyPopulation22112
Government17510
Scientists139878
COVID‐19 vaccine acceptance once the vaccine is available and considered safe and effective by the authoritiesYes, sure62435
Yes, probably69839
No, probably not32218
No, sure not1508
Sample characteristics

Ranking exercise results

The ranking exercise results are summarized in Figures 2 and 3. Figure 2 uses cumulative distribution functions to synthesize how each strategy was ordered by the respondents. There was not one single strategy that dominated and was considered as best by a large majority. The eight strategies were clearly divided into three groups: three dominant strategies, two strategies ranked somewhere in the middle, and three strategies ranked in the three worst strategies. Prioritizing essential workers, chronically ill and elderly were found to be the three most supported strategies. On the other hand, market, lottery or “first‐come, first‐served” strategies were clearly the least preferred strategies with at least 80% of the respondents ranking them at the bottom of the ranking. Finally, targeting spreaders or protecting the economy were strategies ranked in the middle.
FIGURE 2

Cumulative distribution functions of alternative COVID‐19 vaccine allocation strategies ranked from “most suitable” (rank of 1) to “least suitable” (rank of 8)

FIGURE 3

Scatterplot of the ranks of prioritization strategies along with their relationship to age summarized by a regression spline. The graph plots the ranking of each prioritization strategy according to age. Dots toward the left‐ and right‐hand side are rankings of younger and older respondents, respectively. A darker zone around a rank shows the most observed ranking of that strategy. Note that the dots have been uniformly shifted up and down within each rank to avoid over‐plotting (uniform jitter). The red lines summarize for each strategy the relationship between the ranking and the age of the respondent. For example, younger respondents ranked essential professions lower than older respondents as a preferred vaccination strategy

Cumulative distribution functions of alternative COVID‐19 vaccine allocation strategies ranked from “most suitable” (rank of 1) to “least suitable” (rank of 8) Scatterplot of the ranks of prioritization strategies along with their relationship to age summarized by a regression spline. The graph plots the ranking of each prioritization strategy according to age. Dots toward the left‐ and right‐hand side are rankings of younger and older respondents, respectively. A darker zone around a rank shows the most observed ranking of that strategy. Note that the dots have been uniformly shifted up and down within each rank to avoid over‐plotting (uniform jitter). The red lines summarize for each strategy the relationship between the ranking and the age of the respondent. For example, younger respondents ranked essential professions lower than older respondents as a preferred vaccination strategy Figure 3 shows that the attractiveness of strategies was to some extent age‐dependent. Although the overall ranking of strategies was mostly similar across age groups, when compared to younger respondents, older respondents ranked essential professions, elderly and workers higher while younger respondents ranked vaccinating spreaders or alternative strategies such as lottery, first‐come first‐served or markets higher. While the lottery strategy was very unpopular across age groups (79% ranked it in the top three of worst strategies), one in 10 respondents thought that this was a very good strategy and ranked it as the most or second most suitable strategy for allocating vaccines in the population.

DCE results

In total, we analyzed 19,440 choices between hypothetical individuals competing for vaccination. We first estimated a PML model in the five attributes and all possible two‐way interactions between them. All interactions were, however, insignificant or negligible compared to the attribute main effects. Hence, main‐effects model A (see Table 4 and Figure 4) summarizes the average preferences of the whole sample over the five attributes. This model shows that no single attribute dominated the other attributes. Instead, we found that three attributes were of large importance: belonging to a medically vulnerable group due to pre‐existing conditions, having an “essential profession” and being a relatively large spreader of the virus. Both age and cost to society were of statistical significance with higher priority for older and more costly people but these effects were limited. While older people are also labeled as higher risk groups with COVID‐19, being in an older age group was not found to be a strong predictor of vaccine priority by the public. Whether people would be costly to society if they had COVID‐19 did not seem to matter much either.
TABLE 4

Panel mixed logit model estimates for the entire sample and the two clusters

TermModel A (N = 1944)Model B (N = 1058)Model C (N = 886)
Posterior meanPosterior standard deviationSubject standard deviationLower 95%Upper 95%Posterior meanPosterior standard deviationSubject standard deviationLower 95%Upper 95%Posterior meanPosterior standard deviationSubject standard deviationLower 95%Upper 95%
Medical risk group
Yes0.676**0.0240.4460.6320.7240.309**0.0230.0720.2650.3521.394**0.0600.5471.2761.521
No−0.676**0.0240.446−0.724−0.632−0.309**0.0230.072−0.352−0.265−1.394**0.0600.547−1.521−1.276
Older than 60
Yes0.093**0.0150.4420.0640.124−0.202**0.0170.291−0.236−0.1690.504**0.0290.4380.4490.564
No−0.093**0.0150.442−0.124−0.0640.202**0.0170.2910.1690.236−0.504**0.0290.438−0.564−0.449
Virus spreader
10 other persons0.660**0.0240.4680.6140.7080.911**0.0320.4770.8490.9730.480**0.0370.1250.4090.562
1 other person−0.660**0.0240.468−0.708−0.614−0.911**0.0320.477−0.973−0.849−0.480**0.0370.125−0.562−0.409
Cost to society
0 € per day−0.123*0.0260.251−0.173−0.078−0.334**0.0320.273−0.400−0.275−0.0500.0330.130−0.1190.014
100 € per day−0.011*0.0220.146−0.0540.0300.060**0.0290.2240.0020.1140.0040.0390.221−0.0710.072
1000 € per day0.134*0.0270.2620.0820.1870.274**0.0300.2980.2130.3340.0460.0420.240−0.0390.129
Essential profession
Yes0.567**0.0190.5190.5290.6040.362**0.0200.3810.3230.4020.975**0.0460.7370.8861.071
No−0.567**0.0190.519−0.604−0.529−0.362**0.0200.381−0.402−0.323−0.975**0.0460.737−1.071−0.886

** and * Significant at p < 0.001 and p < 0.05, respectively.

FIGURE 4

Estimated utilities of the full sample (N = 1944 respondents), cluster 1 (N = 1058 respondents), and cluster 2 (N = 886 respondents)

Panel mixed logit model estimates for the entire sample and the two clusters ** and * Significant at p < 0.001 and p < 0.05, respectively. Estimated utilities of the full sample (N = 1944 respondents), cluster 1 (N = 1058 respondents), and cluster 2 (N = 886 respondents) Model A with the average preferences showed a large amount of subject heterogeneity and could therefore be misleading in case a population is polarized. This phenomenon is referred to as Simpson's paradox (Simpson, 1951). That is why we investigated individual preferences differences among respondents in a post‐estimation cluster analysis, revealing two large clusters within the sample. The preferences of the first cluster (N = 1058 respondents, 54%) are summarized by model B. This cluster was in favor of prioritizing high virus‐spreaders. The second cluster (N = 886 respondents, 46%), summarized in model C, prioritized vaccinating people with underlying conditions. Both clusters valued essential professions as the second most important attribute. Interestingly however, whereas people aged 60 or more were prioritized in the third place in cluster 2, they were not prioritized in cluster 1. Cluster 1 also valued people who were economically important whereas this attribute was statistically insignificant in cluster 2. Figure 4 presents the utility effects of all three models in predicting respondents' choices. Because a latent class analysis could be a more direct alternative to the cluster analysis on the individual preferences and preferences could be more diverse or segmented than estimated using PML models, we also estimated latent class models to validate our results (see Appendix C). The selected two‐class model revealed two latent classes with preferences comparable to those observed in the clusters from the cluster analysis. The first and second latent classes corresponded to clusters 1 and 2, containing 53% and 47% of the sample, respectively. We analyzed whether there were any individual characteristics associated with membership to either cluster (see Table 5). Compared to those from cluster 2, members of cluster 1 were more likely to be French‐speaking, to be in doubt about whether or not they should become vaccinated with a COVID‐19 vaccine, to think that priorities must be set by the population (instead of by scientists or government), to be unemployed and to have had a COVID‐19 infection that was not test‐confirmed. There was no relationship between being a member of clusters 1 or 2 and respondents' age, having an “essential” profession, financial situation, level of education or other variables in our survey. If we consider that a safe and effective COVID‐19 vaccine was seen as the only way out of the pandemic and that a majority of respondents (74%) reported they would probably or definitely become vaccinated, this absence of relationship suggests that respondents' choices in the experimentation were not driven by self‐interest.
TABLE 5

Multiple logistic regression model for classifying a person in cluster 1 versus cluster 2 based on relevant respondent characteristics and opinions, ranked from most important to least important

p‐Value p‐Value
TermEstimateChi‐squareChi‐squareLR chi‐square
Language
Dutch−0.38456.2120.0000.000
French0.38456.2120.000
COVID‐19 vaccine acceptance
Yes, sure−0.1905.0020.0250.012
Yes, probably0.0540.4280.513
No, probably not0.2616.3670.012
No, sure not−0.1240.8230.364
Determination vaccine prioritization
Population0.3218.0860.0040.015
Government−0.2815.7610.016
Scientists−0.0400.2460.620
Profession
Unemployed0.2274.8000.0280.026
Not unemployed−0.2274.8000.028
Know personally someone who has had COVID‐19
Yes, confirmed with a test−0.2475.7930.0160.032
Probably, but not confirmed with a test0.3106.1400.013
No−0.0630.5990.439
Constant0.53417.0240.0000.000
Multiple logistic regression model for classifying a person in cluster 1 versus cluster 2 based on relevant respondent characteristics and opinions, ranked from most important to least important The PML models that we estimated for the full sample and the two clusters allow us to construct a concrete priority ranking of individuals described in terms of the five attributes we used. To compare the rankings across the different models, we rescaled the total utilities of the individual profiles for each model onto a desirability index ranging from 0 to 1 (or from 0 to 100%). Table 6 presents out of the 48 different profiles that were investigated, the profiles of individuals who would get highest and lowest priority along with the profiles where the differences in the rankings obtained for cluster 1 versus cluster 2 were the largest. The most attractive profile to be first vaccinated according to the full sample is profile A: someone who is part of a medical risk group, older than 60, who is likely to be a high virus spreader, with an economic cost of 1000 € per day in case of illness and who has an essential profession. The least attractive profile was the exact opposite: profile N. When comparing the two clusters, cluster 1 clearly exhibited a likelihood to rank older people with a lower priority, for example, profile C was the most attractive profile to be first vaccinated. The largest gap between the desirability indices between clusters 1 and 2 was observed in profile G. In Figure 5 we show the correlation between the desirability indices of the 48 different profiles according to each of the two clusters and pin‐point the profiles that were the most outspoken with their letter.
TABLE 6

Ranking of individual profiles: the four most (A to D) and the four least (K to N) attractive profiles out of 48 options, and six profiles (E to J) with the largest difference in desirability between the clusters 1 and 2 respondents

ProfileAttributesFull sampleCluster 1Cluster 2
Medical risk groupOlder than 60Virus spreaderEconomic impact (€ per day)Essential professionDesirability indexRankDesirability indexRankDesirability indexRank
AYesYesYes1000Yes0.99010.89330.9901
BYesYesYes100Yes0.95520.84460.9852
CYesNoYes1000Yes0.94630.99010.8446
DYesYesYes0Yes0.93140.747110.9773
EYesYesNo100Yes0.651130.411300.8465
FNoNoYes1000Yes0.634170.84540.44227
GYesYesNo0Yes0.627180.317350.8388
HNoNoYes1000No0.373310.670150.16142
IYesYesNo0No0.366320.150450.55823
JNoNoYes100No0.339360.622180.15643
KNoNoNo1000No0.069450.244390.02346
LNoYesNo0No0.054460.010480.15644
MNoNoNo100No0.034470.197420.01747
NNoNoNo0No0.010480.104460.01048
FIGURE 5

Scatterplot of desirability values of the 48 different profiles for cluster 1 versus cluster 2 where the four most attractive profiles (A to D) and the four least attractive profiles (K to N) are indicated along with profiles E to J that exhibit the largest difference in desirability indices between clusters 1 and 2 (see Table 6). Profiles with a letter fall outside the 75% density ellipse

Ranking of individual profiles: the four most (A to D) and the four least (K to N) attractive profiles out of 48 options, and six profiles (E to J) with the largest difference in desirability between the clusters 1 and 2 respondents Scatterplot of desirability values of the 48 different profiles for cluster 1 versus cluster 2 where the four most attractive profiles (A to D) and the four least attractive profiles (K to N) are indicated along with profiles E to J that exhibit the largest difference in desirability indices between clusters 1 and 2 (see Table 6). Profiles with a letter fall outside the 75% density ellipse

DISCUSSION

This study shows how the population living in Belgium wanted to prioritize long‐awaited COVID‐19 vaccinations across the population at a time when widely diverging allocation strategies were possible. First, there was little support for libertarian‐inspired approaches such as highest willingness‐to‐pay on a private vaccine market or “first‐come, first served” strategies. A strict egalitarian approach like a lottery also received little support. Instead, the most supported strategies were those where priority groups were explicitly defined at a policy level. Second, when asked to rank different vaccine allocation strategies, respondents would prioritize groups of the population similar to the ones that were eventually used and also identified in other studies (Duch et al., 2021; Gollust et al., 2020), namely targeting health workers and old and ill people at high risk of severe COVID‐19 or death. However, as soon as we asked participants to make choices between hypothetical individuals after being provided with information about what being a high virus spreader or costly to society meant, their preferences leant toward a vaccination strategy simultaneously prioritizing medically vulnerable groups, high virus spreaders, and essential workers but no longer including older people as a priority group. This was also true for respondents from older age groups. This result is similar to Persad et al. (2020), who found that vaccinating healthy older adults was a lower priority in their study. Interestingly, the general public would also not prioritize for vaccination those who are of particular economic importance such as those who work. Third, when trying to compare and rank within the three main target groups identified within the DCE, the population was divided in two clusters, each highlighting a separate function of vaccination. One share adhered to a strategy that we could label “utilitarian” since it would aim to maximize societal health outcomes by allocating vaccines strategically toward virus spreaders (cluster one) (Savulescu et al., 2020). These people also thought that vaccinating those with high economic cost to society was to some extent important. The other cluster adhered more toward a “prioritarian” strategy that put people who are at medically highest risk first (cluster two). Being a virus spreader or someone who could cost a lot to the economy was of little or no importance in this cluster. However, both groups considered essential professions a priority group but of secondary importance. Age was of minor importance in both groups; however prioritizing people older than 60 was positioned higher in the “prioritarian” group than in the “utilitarian” group where a slight priority was given to younger people. Such findings would be compatible with a “fair innings” argument according to which age is an accepted criterion for scarce health care resources allocation (Williams & Evans, 1997). It was not the case that membership of these clusters coincided with the characteristics of the respondents. For instance, there was no relationship between priority choices and being young (respectively old) or with having an essential profession or not. While respondents who were not working (students, retired or unemployed people and homemakers) were more likely to be part of the “utilitarian” cluster and those belonging to a COVID‐19 higher risk group were more likely part of the “prioritarian” cluster, those correlations disappeared when multiple respondent characteristics were considered simultaneously. Although by now there is an international policy consensus on the broad priority candidates to the COVID‐19 vaccines, at the time when little information was available, many mechanisms to distribute vaccines were possible. As we showed, there was not an easy consensus in the general population. Depending on the method of surveying, that is, ranking options or discrete choices, our study shows that either elderly or virus spreaders were top‐priority groups. Moreover, ranking within key groups was not straightforward either. This is nonetheless required as the identified priority groups constitute a sizable fraction of the population already, especially when risk groups or essential professions are defined broadly. The difficulty of defining a clear ranking among the identified priority groups has also been observed in the initial COVID‐19 vaccination strategies put forward by the European Commission and World Health Organization Strategic Advisory Group of Experts on Immunization (European Commission, 2020; World Health Organization, 2020). Whereas these argued that when ranking between priority groups becomes unavoidable, risk groups should go first, the US National Academies of Sciences, Engineering, and Medicine argued to do the opposite and suggested giving the vaccine first to essential workers. Our experiment allowed us to construct a concrete ranking of individuals. However, such ranking was not based on membership to one particular group but on a combination of five characteristics. Rationing based on such an individual priority‐score obtained over various relevant characteristics would be a more refined approach to priority setting than the current approach of selecting entire population subgroups but is less convenient for operational and political reasons. Our study had the following limitations. One was the lack of a distinction within essential workers, especially since the health and social care workers have often been considered as top‐priority groups. However, arguably, there is a different logic present in prioritizing health care workers versus other essential professions such as teachers or police. Another limitation was that, while our sample was broadly representative of the population in Belgium, it was recruited from an online panel where membership may be associated with unobserved characteristics (e.g., Internet access). In case these characteristics would translate into different preferences, our results would reflect these. Also, we investigated people's preferences for a hypothetical vaccine. However, the suitability of vaccination strategies obviously depends on the specific characteristics of the vaccine and these only become known when the vaccination program is fully rolled out. For instance, if the vaccine is less effective in older or immunocompromised individuals, it would be less desirable to prioritize these groups. Likewise, if the vaccine protects against severe COVID‐19 symptoms but does not reduce contagion of others then a strategy targeting spreaders becomes useless. The weakness of our study is therefore to assume that the vaccine was simplistic and idealistic, that is, safe and effective in all population subgroups and simultaneously reducing symptoms and infectiousness. A final note to conclude is that the importance given to public preferences is a matter of debate. It is undoubtedly important to include public opinion in a policy of large collective importance and in which there is interdependence between policy measures' effectiveness and public goodwill and participation. However, it does not mean that the public would like to define the norm: when asked who should ultimately get the mandate to determine priority groups, 78% of our respondents indicated scientists. Only about 10% stated that the population's preferences should be followed.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

ETHICS STATEMENT

The Social and Societal Ethics Committee (SMEC) of KU Leuven decided that this study did not fall under the Belgian law on experiments as pseudonymized data collected by a third party were analyzed. No ethics approval was deemed necessary.
TABLE A1

Study sample representativeness compared to the overall Belgian population

VariablesCategoriesStudy sample (%)Belgian population a (%)
GenderFemale5151
Male4949
Age18–241011
25–341716
35–441717
45–541918
55–641716
65–802022
LanguageDutch5760
French4340
ProvinceVlaams‐Brabant1010
Brabant Wallon73
Brussels Capital910
Antwerpen1516
Limburg88
East Flanders1313
West Flanders1011
Hainaut612
Liège1010
Luxembourg53
Namur84
EducationNone or primary school2634
Secondary school3537
Higher education3929
COVID‐19 vaccine acceptanceWilling or likely to be vaccinated7469
Hesitant or unlikely to be vaccinated2630
Difficulties with monthly expensesNever or once a year/no or little difficulty in making ends meet6378
Once every 3 months or every month/difficulty in making ends meet3722
Self‐assessed healthVery good1425
Good4152
Fair3417
Poor95
Very poor11
Don't know/don't want to say1NA

Sources used: Age, gender, language, province, and education (Statbel, 2021); self‐assessed health and financial situation (Sciensano, 2021); willingness to be vaccinated in September 2020 (UA, 2020).

TABLE B1

Bayesian D‐optimal partial profile design including three surveys

TABLE C1

Latent class model estimates for the sample choice data

TermClass 1 (N = 1036)Class 2 (N = 908)
MeanStandard errorLower 95%Upper 95%MeanStandard errorLower 95%Upper 95%
Medical risk group
Yes0.172**0.0220.1290.2150.821**0.0370.7480.894
No−0.172**0.022−0.215−0.129−0.821**0.037−0.894−0.748
Older than 60
Yes−0.145**0.021−0.187−0.1030.317**0.0230.2710.363
No0.145**0.0210.1030.187−0.317**0.023−0.363−0.271
Virus spreader
10 other persons0.481**0.0220.4380.5240.302**0.0270.2480.356
1 other person−0.481**0.022−0.524−0.438−0.302**0.027−0.356−0.248
Cost to society
0 € per day−0.182**0.025−0.232−0.132−0.0520.035−0.1200.016
100 € per day0.0030.024−0.0440.0500.0330.026−0.0180.084
1000 € per day0.179**0.0260.1270.2310.0390.036−0.0310.109
Essential profession
Yes0.220**0.0250.1720.2680.753**0.0290.6970.809
No−0.220**0.025−0.268−0.172−0.753**0.029−0.809−0.697
Class membership constant0.1210.089−0.0530.296
Class share53%47%

** Significant at p < 0.001.

  31 in total

1.  Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: a discrete choice experiment.

Authors:  Julie Ratcliffe; Hilary L Bekker; Paul Dolan; Richard Edlin
Journal:  Health Policy       Date:  2008-10-19       Impact factor: 2.980

2.  The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments.

Authors:  F Reed Johnson; Jui-Chen Yang; Shelby D Reed
Journal:  Value Health       Date:  2018-09-27       Impact factor: 5.725

3.  Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment.

Authors:  Jeroen Luyten; Roselinde Kessels; Katherine E Atkins; Mark Jit; Albert Jan van Hoek
Journal:  Soc Sci Med       Date:  2019-03-20       Impact factor: 4.634

4.  Latent Class Analysis: An example for reporting results.

Authors:  James B Schreiber
Journal:  Res Social Adm Pharm       Date:  2016-11-30

5.  COVID-vaccine results are on the way - and scientists' concerns are growing.

Authors:  Smriti Mallapaty; Heidi Ledford
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

6.  "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.

Authors:  Barry R Bloom; Glen J Nowak; Walter Orenstein
Journal:  N Engl J Med       Date:  2020-09-08       Impact factor: 91.245

7.  How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton.

Authors:  Laurence S J Roope; John Buckell; Frauke Becker; Paolo Candio; Mara Violato; Jody L Sindelar; Adrian Barnett; Raymond Duch; Philip M Clarke
Journal:  Pharmacoecon Open       Date:  2020-12

8.  Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments.

Authors:  Marcel F Jonker; Bas Donkers; Esther de Bekker-Grob; Elly A Stolk
Journal:  Health Econ       Date:  2018-12-18       Impact factor: 3.046

9.  Public Perspectives on COVID-19 Vaccine Prioritization.

Authors:  Govind Persad; Ezekiel J Emanuel; Samantha Sangenito; Aaron Glickman; Steven Phillips; Emily A Largent
Journal:  JAMA Netw Open       Date:  2021-04-01

10.  Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.

Authors:  Jeroen Luyten; Sandy Tubeuf; Roselinde Kessels
Journal:  Health Econ       Date:  2021-11-17       Impact factor: 2.395

View more
  2 in total

1.  Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.

Authors:  Jeroen Luyten; Sandy Tubeuf; Roselinde Kessels
Journal:  Health Econ       Date:  2021-11-17       Impact factor: 2.395

2.  Applications of discrete choice experiments in COVID-19 research: Disparity in survey qualities between health and transport fields.

Authors:  Milad Haghani; Michiel C J Bliemer; Esther W de Bekker-Grob
Journal:  J Choice Model       Date:  2022-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.